Clostridium difficile DNA polymerase IIIC: Basis for activity of anti-bacterial compounds

Current Enzyme Inhibition

Volumn 7, Issue 3, 2011, Pages 147-153

  Torti, Andrea ^a   Lossani, Andrea ^a   Savi, Lida ^a   Focher, Federico ^a   Wright, George E ^b   Brown, Neal C ^b   Xu, Wei Chu ^b  

^a CNR   (Italy)

^b GLSYNTHESIS INC   (United States)

Author keywords

Antibacterials; C. difficile; Competitive inhibitors; Dna polymerase; Replication

Indexed keywords

BACTERIAL DNA; DEOXYGUANOSINE TRIPHOSPHATE; DNA POLYMERASE; DNA POLYMERASE IIIC; ENZYME INHIBITOR; IMIDAZOLE; LYSOZYME; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; ENZYME ASSAY; ENZYME PURIFICATION; MOLECULAR CLONING; NONHUMAN;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; POSIBACTERIA;

EID: 84855286086     PISSN: 15734080     EISSN: 18756662     Source Type: Journal    
DOI: 10.2174/157340811798807597     Document Type: Article

References (22)

1. Johnson, S.; Gerding, D.N. Clostridium difficile-associated diarrhea. Clin. Infect. Dis., 1998, 26, 1027-1036.
2. McFarland, L.V. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat. Clin. Pract. Gastroenterol. Hepatol., 2008, 5, 40-48.
3. Kelly, C.P.; LaMont, J.T. Clostridium difficile - More Difficult Than Ever. N. Engl. J. Med., 2008, 359, 1932-1940.
4. Zilberberg, M.D.; Shorr, A.F.; Kollef, M.H. Increase in adult Clostridium difficile-related Hospitalizations and Case-Fatality Rate., United States, 2000-2005. Emerging Infect. Dis., 2008, 14, 929-931.
5. Hammond, R.A.; Barnes, M.H.; Mack, S.L.; Mitchener, J.A.; Brown, N.C. Bacillus subtilis DNA polymerase III: complete sequence, overexpression, and characterization of the polC gene. Gene, 1991, 98, 29-36.
6. Pacitti, D.; Barnes, M.; Li, D.; Brown, N. Characterization and overexpression of the gene encoding Staphylococcus aureus DNA polymerase III. Gene, 1995, 165, 51-56.
7. Foster, K.A.; Barnes, M.H.; Stephenson, R.O.; Butler, M.M.; Skow, D.J.; LaMarr, W.A.; Brown, N.C. DNA polymerase III of Enterococcus faecalis: expression and characterization of recombinant enzymes encoded by the polC and dnaE genes. Prot. Exp. Purif., 2003, 27, 90-97.
8. Clements, J.E.; D'Ambrosio, J.; Brown, N.C. Inhibition of Bacillus subtilis deoxyribonucleic acid polymerase III by phenylhydrazinopyrimidines. Demonstration of a drug-induced deoxyribonucleic acid-enzyme complex. J. Biol. Chem., 1975, 250, 522-526.
9. Zhi, C.; Long, Z.; Gambino, J.; Xu, W.; Brown, N.C.; Barnes, M.; Butler, M.; LaMarr, W.A.; Wright, G.E. Synthesis of Substituted 6- Anilinouracils and Their Inhibition of DNA Polymerase IIIC and Gram-positive Bacterial Growth. J. Med. Chem., 2003, 46, 2731-2739.
10. Wright, G.E.; Brown, N.C.; Xu, W.; Long, Z.; Zhi, C.; Gambino, J.J.; Barnes, M.H.; Butler, M.M. Active site directed inhibitors of replication-specific bacterial DNA polymerases. Bioorg. Med. Chem. Lett., 2005, 15, 729-732.
11. Zhi, C.; Long, Z.-Y.; Manikowski, A.; Brown, N.C.; Tarantino, Jr., P.M.; Holm, K.; Dix, E.J.; Wright, G.E.; Foster, K.A.; Butler, M.M.; LaMarr, W.A.; Skow, D.J.; Motorina, I.; Lamothe, S; Storer, R. Synthesis and Antibacterial Activity of 3-Substituted-6-(3-ethyl- 4-methylanilino)uracils. J. Med. Chem., 2005, 48, 7063-7074.
12. Xu, W.-C.; Wright, G.E.; Brown, N.C.; Long, Z.; Zhi, C.; Gambino, J.J.; Barnes, M.H.; Butler, M.M. Deazaguanines and Related Inhibitors of Bacterial DNA Polymerase III. Synthesis and Antibacterial Activity. Bioorg. Med. Chem. Lett., 2011, 21, 4197-4202.
13. Wright, G.E.; Brown, N.C. Inhibitors of Bacillus Subtilis DNA Polymerase III. 6-Anilinouracils and 6-(Alkylamino)uracils. J. Med. Chem., 1980, 23, 34-38.
14. Clinical and Laboratory Standards Institute (CLSI), Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard-Seventh Edition, CLSI document M11-A7, 2007.
15. Sebaihia, M.; Wren, B.W.; Mullany, P.; Fairweather, N.F.; Minton, N.; Stabler, R.; Thomson, N.R.; Roberts, A.P.; Cerdeño-Tárraga, A.M.; Wang, H.; Holden, M.T.G.; Wright, A.; Churcher, C.; Quail, M.A.; Baker, S.; Bason, N.; Brooks, K.; Chillingworth, T.; Cronin, A.; Davis, P.; Dowd, L.; Fraser, A.; Feltwell, T.; Hance, Z.; Holroyd, S.; Jagels, K.; Moule, S.; Mungall, K.; Price, C.; Rabbinowitsch, E.; Sharp, S.; Simmonds, M.; Stevens, K.; Unwin, L.; Whithead, S.; Dupuy, B.; Dougan, G.; Barrell, B; Parkhill, J. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet., 2006, 38, 779-786.
16. Butler, M.M.; Wright, G.E. A Method to Assay Inhibitors of DNA Polymerase III Activity. In: New Antibiotic Targets; W.S. Champney (Ed.); Humana Press Inc.; Totowa NJ, 2008, pp. 25-36.
17. Barnes, M.H.; Brown, N.C. Antibody to B. subtilis DNA polymerase III: use in enzyme purification and examination of homology among replication-specific DNA polymerases. Nucl. Acids Res., 1979, 6, 1203-1219.
18. Wright, G.E.; Brown, N.C. Inhibition of Bacillus subtilis DNA Polymerase III by Arylhydrazinopyrimidines: Novel Properties of 2-Thiouracil Derivatives. Biochim. Biophys. Acta, 1976, 432, 37-48.
19. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem., 1976, 72, 248-254.
20. Rial, D.V.; Ceccarelli, E.A. Removal of DnaK contamination during fusion protein purifications. Prot. Expr. Purif., 2002, 25, 503-507.
21. Evans, R.J.; Davies, D.R.; Bullard, J.M. Christensen, J.; Green, L.S.; Guiles, J.W.; Pata, J.D.; Ribble, W.K.; Janjic, N.; Jarvis, T.C. Structure of PolC reveals unique DNA binding and fidelity determinants. Proc. Natl. Acad. Sci. USA, 2008, 105, 20695-20700.
22. Barnes, M.H.; Brown, N.C. Purification of DNA polymerase III of Gram-positive bacteria. Methods Enzymol., 1995, 262, 35-42.